Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-05-31 @ 5:02 AM
Study NCT ID:
NCT05498220
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-02
First Post:
2022-08-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Sponsor:
Organization: